A TLR7 agonist
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

LHC165 (hydrate)

Item No. 38776

Technical Information
Formal Name
5-amino-2-[2-[4-[2-(3,3-difluoro-3-phosphonopropoxy)ethoxy]-2-methylphenyl]ethyl]-benzo[f][1,7]naphthyridine-8-propanoic acid, hydrate
Molecular Formula
C29H32F2N3O7P • XH2O
Formula Weight
Purity
≥95%
Formulation
A solid
DMSO: 30 mg/ml
λmax
233 nm
SMILES
NC1=C(N=C2)C(C=C2CCC(C=CC(OCCOCCC(F)(F)[P](O)(O)=O)=C3)=C3C)=C(C=CC(CCC(O)=O)=C4)C4=N1.O
InChi Code
InChI=1S/C29H32F2N3O7P.H2O/c1-18-14-22(41-13-12-40-11-10-29(30,31)42(37,38)39)7-6-21(18)5-2-20-15-24-23-8-3-19(4-9-26(35)36)16-25(23)34-28(32)27(24)33-17-20;/h3,6-8,14-17H,2,4-5,9-13H2,1H3,(H2,32,34)(H,35,36)(H2,37,38,39);1H2
InChi Key
AIYLPQQMABCVIZ-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Cayman Chemical
    Neutrophil Biology Wall Poster

    Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.

    DOWNLOAD NOW
    Product Description

    LHC165 is a toll-like receptor 7 (TLR7) agonist.1

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Zawit, M., Swami, U., Awada, H., et alCurrent status of intralesional agents in treatment of malignant melanoma. Ann. Transl. Med. 9(12), 1038 (2021).